Galen Holdings PLC announced that Warner Chilcott, Inc. a subsidiary of Galen has received 3 year Hatch/Waxman exclusivity for the new Ovcon-35 tablets, chewable. This exclusivity will expire November 14, 2006. This information was published on January 14, 2004 in the update to Patent Term Extension and New Patents Docket Number 95S-0117.

The company already announced in December 2003 that this product would also be covered by a patent, US Patent No 6667050, issued by the United States Patent and Trademark Office for chewable oral contraceptives.

Galen is a specialty pharmaceutical company based in Craigavon, Northern Ireland and Rockaway, New Jersey, US. The Galen group of companies develops, acquires and manufactures branded prescription pharmaceutical products.